Multiple studies in the first decade of the 21st century have established contrast‐enhanced
breast MRI as a screening modality for women with a hereditary or familial increased risk for …

Purpose: To synthesize new data on breast cancer screening for the US Preventive Services
Task Force. Data Sources: MEDLINE; the Cochrane Controlled Trials Registry; and …

The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and
Pancreatic focus primarily on assessment of pathogenic or likely pathogenic variants …

乳腺癌是中国女性最常见的恶性肿瘤, 发病率位居中国女性恶性肿瘤首位. 国家癌症中心受国家
卫生健康委员会疾病预防控制局委托, 根据《 世界卫生组织指南制定手册》 …

Purpose To evaluate the breast cancer screening efficacy of mammography, ultrasound, and
magnetic resonance imaging (MRI) in a high-risk population and in various population …

Background The value of regular surveillance for breast cancer in women with a genetic or
familial predisposition to breast cancer is currently unproven. We compared the efficacy of …

Purpose To compare the effectiveness of mammography, breast ultrasound, and magnetic
resonance imaging (MRI) for surveillance of women at increased familial risk for breast …

ContextCurrent recommendations for women who have a BRCA1 or BRCA2 mutation are to
undergo breast surveillance from age 25 years onward with mammography annually and …

ContextBreast cancer screening in community practices may be different from that in
randomized controlled trials. New screening modalities are becoming available …

Background Women genetically predisposed to breast cancer often develop the disease at a
young age when dense breast tissue reduces the sensitivity of X-ray mammography. Our …